摘要
目的合成盐酸埃他卡林的氘定位标记化合物 ,确证盐酸埃他卡林的质谱裂解途径。方法由 2 ,3 二甲基 2 丁胺与 (N 2 H7)溴代异丙烷缩合而得到氘标记盐酸埃他卡林 ;测定盐酸埃他卡林、(N 2 H7)盐酸埃他卡林及两者混合物的质谱 (EI)。结果利用核磁共振氢谱、质谱、红外光谱和元素分析对目标化合物进行了结构确证。通过对比氘标记和非标记的盐酸埃他卡林的质谱图 ,确定了盐酸埃他卡林的质谱裂解途径。
Aim To synthesize deuterium labelled iptakalim hydrochloride and confirm the MS fragment pathways of iptakalim hydrochloride.Methods The deuterium labelled iptakalim hydrochloride was obtained by the condensation of 2,3-dimethyl-2-butamine with (~2H_7)2-bromopropane.The un-reacted 2,3-dimethyl-2-butamine was derivated to its amide.The (N-~2H_7)iptakalim hydrochloride could be easily separated from the reaction mixture.Results ~1H-NMR,MS,IR and elemental analysis confirmed the structure of(N-~2H_7)iptakalim hydrochloride.The MS fragment pathways of iptakalim hydrochloride were proposed by comparing the mass spectra of iptakalim hydrochloride,(N-~2H_7)iptakalim hydrochloride and the mixture of the two compounds were proposed.Conclusion Mass spectroscopy with isotope labelled compounds as the internal standard provides a convenient method to propose the fragment pathways of drugs.
出处
《中国药物化学杂志》
CAS
CSCD
2004年第3期161-164,共4页
Chinese Journal of Medicinal Chemistry
基金
国家 10 35工程资助项目 (96 90 10 10 1)
关键词
药物化学
制备
化学合成
质谱裂解途径
盐酸埃他卡林
氘标记
medicinal chemistry
preparation
chemical synthesis
MS fragment pathways
iptakalim hydrochloride
labelled deuterium